Show simple item record

dc.contributor.authorGoyal, Amit
dc.date.accessioned2018-12-04T14:47:12Z
dc.date.available2018-12-04T14:47:12Z
dc.date.issued2018-10
dc.identifier.citationBreast Care (Basel). 2018 Oct;13(5):349-353. doi: 10.1159/000492436. Epub 2018 Sep 18.en
dc.identifier.urihttps://orda.derbyhospitals.nhs.uk/handle/123456789/1699
dc.descriptionAuthor(s) Pre or Post Print Version Onlyen
dc.description.abstractThe 'standard of care' method for sentinel node mapping is the combination technique using radioisotope and blue dye although some centres use radioisotope or blue dye alone. Radioisotope usage requires licensing, has regulatory issues around handling and disposal of waste, and logistically may be unavailable or difficult to implement in some centres or less developed country. This has led to the development of alternative methods such as superparamagnetic iron oxide (SPIO), fluorescence techniques using indocyanine green (ICG) or fluorescein, computed tomography lymphography, and contrast-enhanced ultrasound scan (CEUS) using microbubbles. The newer techniques will potentially enable a more widespread adoption of this procedure; however, a common barrier for these techniques is the lack of standardisation and no randomised trials to evaluate their effectiveness against the current standard of care. Furthermore, many of these techniques are more costly and may become redundant in node-negative patients with small tumours if ongoing trials show that sentinel node biopsy offers no additional benefit to grey-scale axillary ultrasound. This review discusses the new techniques for sentinel node mapping that have emerged including their pros and cons.en
dc.language.isoenen
dc.subjectSentinel Lymph Nodeen
dc.subjectMappingen
dc.titleNew Technologies for Sentinel Lymph Node Detection.en
dc.typeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record